In last trading session, Nutex Health Inc (NASDAQ:NUTX) saw 0.69 million shares changing hands with its beta currently measuring -0.02. Company’s recent per share price level of $122.9 trading at $4.44 or 3.75% at ring of the bell on the day assigns it a market valuation of $682.72M. That closing price of NUTX’s stock is at a discount of -49.93% from its 52-week high price of $184.27 and is indicating a premium of 96.62% from its 52-week low price of $4.16. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.2 million shares which gives us an average trading volume of 152.37K if we extend that period to 3-months.
For Nutex Health Inc (NUTX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -5.43 in the current quarter.
Nutex Health Inc (NASDAQ:NUTX) trade information
Upright in the green during last session for gaining 3.75%, in the last five days NUTX remained trading in the green while hitting it’s week-highest on Friday, 06/27/25 when the stock touched $122.9 price level, adding 2.09% to its value on the day. Nutex Health Inc’s shares saw a change of 2063.73% in year-to-date performance and have moved 7.91% in past 5-day. Nutex Health Inc (NASDAQ:NUTX) showed a performance of -25.74% in past 30-days. Number of shares sold short was 0.36 million shares which calculate 2.17 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 45 to the stock, which implies a fall of -173.11% to its current value. Analysts have been projecting 45 as a low price target for the stock while placing it at a high target of 45. It follows that stock’s current price would jump 63.38% in reaching the projected high whereas dropping to the targeted low would mean a gain of 63.38% for stock’s current value.
Nutex Health Inc (NUTX) estimates and forecasts
This year revenue growth is estimated to rise 54.87% from the last financial year’s standing.
3 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 176.47M for the same. And 3 analysts are in estimates of company making revenue of 173.22M in the next quarter. Company posted 76.08M and 78.79M of sales in current and next quarters respectively a year earlier.
Nutex Health Inc (NASDAQ:NUTX)’s Major holders
Insiders are in possession of 39.78% of company’s total shares while institution are holding 18.53 percent of that, with stock having share float percentage of 30.76%. Investors also watch the number of corporate investors in a company very closely, which is 18.53% institutions for Nutex Health Inc that are currently holding shares of the company. WEALTHCOLLAB, LLC is the top institutional holder at NUTX for having 0.13 million shares of worth $12157.0. And as of 2024-06-30, it was holding 0.2548 of the company’s outstanding shares.
The second largest institutional holder is RHUMBLINE ADVISERS, which was holding about 976.0 shares on 2024-06-30. The number of shares represents firm’s hold over 0.002 of outstanding shares, having a total worth of $580.0.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and American Century ETF Trust-Avantis U.S. Small Cap Value ETF are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 83.07 shares of worth $10.21 million or 1.50% of the total outstanding shares. The later fund manager was in possession of 71.56 shares on May 31, 2025 , making its stake of worth around $8.79 million in the company or a holder of 1.29% of company’s stock.
